Cargando…
Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation
PURPOSE: Two randomized controlled trials (RCTs), Mitra-Fr and Coapt, evaluating the benefit of percutaneous repair (PR) for heart failure (HF) patients with severe mitral regurgitation, have led to conflicting results. We aimed to evaluate the impact of these trial results on the cost-effectiveness...
Autores principales: | Armoiry, Xavier, Obadia, Jean-François, Auguste, Peter, Connock, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652317/ https://www.ncbi.nlm.nih.gov/pubmed/33166308 http://dx.doi.org/10.1371/journal.pone.0241361 |
Ejemplares similares
-
Mitral regurgitation: lessons learned from COAPT and MITRA-Fr
por: Nappi, Francesco, et al.
Publicado: (2020) -
Tratamento Percutâneo da Insuficiência Mitral Secundária por MitraClip: Mitra-FR versus COAPT
por: Barros-Gomes, Sergio, et al.
Publicado: (2021) -
Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair
por: Connock, Martin, et al.
Publicado: (2023) -
Why Did COAPT Win While MITRA-FR Failed? Defining the Appropriate Patient Population for MitraClip
por: Atianzar, Kimberly, et al.
Publicado: (2019) -
MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results
por: Pibarot, Philippe, et al.
Publicado: (2019)